Global Tumor Multigene Detection Kit Market Growth 2026-2032
The global Tumor Multigene Detection Kit market size is predicted to grow from US$ 1302 million in 2025 to US$ 3743 million in 2032; it is expected to grow at a CAGR of 16.6% from 2026 to 2032.
Tumor NGS detection kit is an experimental consumable used in tumor detection
United States market for Tumor Multigene Detection Kit is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Tumor Multigene Detection Kit is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Tumor Multigene Detection Kit is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Tumor Multigene Detection Kit players cover Roche Foundation Medicine, Illumina Inc., Life Technologies Corporation, Thermo Fisher Scientific, Memorial Sloan Kettering, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Tumor Multigene Detection Kit Industry Forecast” looks at past sales and reviews total world Tumor Multigene Detection Kit sales in 2025, providing a comprehensive analysis by region and market sector of projected Tumor Multigene Detection Kit sales for 2026 through 2032. With Tumor Multigene Detection Kit sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tumor Multigene Detection Kit industry.
This Insight Report provides a comprehensive analysis of the global Tumor Multigene Detection Kit landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Tumor Multigene Detection Kit portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Tumor Multigene Detection Kit market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tumor Multigene Detection Kit and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tumor Multigene Detection Kit.
This report presents a comprehensive overview, market shares, and growth opportunities of Tumor Multigene Detection Kit market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Tumor NGS detection kit is an experimental consumable used in tumor detection
United States market for Tumor Multigene Detection Kit is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Tumor Multigene Detection Kit is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Tumor Multigene Detection Kit is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Tumor Multigene Detection Kit players cover Roche Foundation Medicine, Illumina Inc., Life Technologies Corporation, Thermo Fisher Scientific, Memorial Sloan Kettering, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Tumor Multigene Detection Kit Industry Forecast” looks at past sales and reviews total world Tumor Multigene Detection Kit sales in 2025, providing a comprehensive analysis by region and market sector of projected Tumor Multigene Detection Kit sales for 2026 through 2032. With Tumor Multigene Detection Kit sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tumor Multigene Detection Kit industry.
This Insight Report provides a comprehensive analysis of the global Tumor Multigene Detection Kit landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Tumor Multigene Detection Kit portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Tumor Multigene Detection Kit market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tumor Multigene Detection Kit and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tumor Multigene Detection Kit.
This report presents a comprehensive overview, market shares, and growth opportunities of Tumor Multigene Detection Kit market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Reversible End Termination Sequencing
- Semiconductor Sequencing
- Combined Probe Anchored Polymerization Sequencing
- Companion Diagnostics
- Early Cancer Screening
- Drug Discovery
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Roche Foundation Medicine
- Illumina Inc.
- Life Technologies Corporation
- Thermo Fisher Scientific
- Memorial Sloan Kettering
- Novogene
- Geneseeq
- AmoyDx
- Burning Rock Medicine
- NantHealth
- Personal Genome Diagnostics
- GTH.O
- What is the 10-year outlook for the global Tumor Multigene Detection Kit market?
- What factors are driving Tumor Multigene Detection Kit market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Tumor Multigene Detection Kit market opportunities vary by end market size?
- How does Tumor Multigene Detection Kit break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Tumor Multigene Detection Kit Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Tumor Multigene Detection Kit by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Tumor Multigene Detection Kit by Country/Region, 2021, 2025 & 2032
2.2 Tumor Multigene Detection Kit Segment by Type
2.2.1 Reversible End Termination Sequencing
2.2.2 Semiconductor Sequencing
2.2.3 Combined Probe Anchored Polymerization Sequencing
2.2.4 Tumor Multigene Detection Kit Sales by Type
2.2.4.1 Global Tumor Multigene Detection Kit Sales Market Share by Type (2021-2026)
2.2.4.2 Global Tumor Multigene Detection Kit Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Tumor Multigene Detection Kit Sale Price by Type (2021-2026)
2.3 Tumor Multigene Detection Kit Segment by Application
2.3.1 Companion Diagnostics
2.3.2 Early Cancer Screening
2.3.3 Drug Discovery
2.3.4 Other
2.3.5 Tumor Multigene Detection Kit Sales by Application
2.3.5.1 Global Tumor Multigene Detection Kit Sale Market Share by Application (2021-2026)
2.3.5.2 Global Tumor Multigene Detection Kit Revenue and Market Share by Application (2021-2026)
2.3.5.3 Global Tumor Multigene Detection Kit Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Tumor Multigene Detection Kit Breakdown Data by Company
3.1.1 Global Tumor Multigene Detection Kit Annual Sales by Company (2021-2026)
3.1.2 Global Tumor Multigene Detection Kit Sales Market Share by Company (2021-2026)
3.2 Global Tumor Multigene Detection Kit Annual Revenue by Company (2021-2026)
3.2.1 Global Tumor Multigene Detection Kit Revenue by Company (2021-2026)
3.2.2 Global Tumor Multigene Detection Kit Revenue Market Share by Company (2021-2026)
3.3 Global Tumor Multigene Detection Kit Sale Price by Company
3.4 Key Manufacturers Tumor Multigene Detection Kit Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Tumor Multigene Detection Kit Product Location Distribution
3.4.2 Players Tumor Multigene Detection Kit Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR TUMOR MULTIGENE DETECTION KIT BY GEOGRAPHIC REGION
4.1 World Historic Tumor Multigene Detection Kit Market Size by Geographic Region (2021-2026)
4.1.1 Global Tumor Multigene Detection Kit Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Tumor Multigene Detection Kit Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Tumor Multigene Detection Kit Market Size by Country/Region (2021-2026)
4.2.1 Global Tumor Multigene Detection Kit Annual Sales by Country/Region (2021-2026)
4.2.2 Global Tumor Multigene Detection Kit Annual Revenue by Country/Region (2021-2026)
4.3 Americas Tumor Multigene Detection Kit Sales Growth
4.4 APAC Tumor Multigene Detection Kit Sales Growth
4.5 Europe Tumor Multigene Detection Kit Sales Growth
4.6 Middle East & Africa Tumor Multigene Detection Kit Sales Growth
5 AMERICAS
5.1 Americas Tumor Multigene Detection Kit Sales by Country
5.1.1 Americas Tumor Multigene Detection Kit Sales by Country (2021-2026)
5.1.2 Americas Tumor Multigene Detection Kit Revenue by Country (2021-2026)
5.2 Americas Tumor Multigene Detection Kit Sales by Type (2021-2026)
5.3 Americas Tumor Multigene Detection Kit Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tumor Multigene Detection Kit Sales by Region
6.1.1 APAC Tumor Multigene Detection Kit Sales by Region (2021-2026)
6.1.2 APAC Tumor Multigene Detection Kit Revenue by Region (2021-2026)
6.2 APAC Tumor Multigene Detection Kit Sales by Type (2021-2026)
6.3 APAC Tumor Multigene Detection Kit Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Tumor Multigene Detection Kit by Country
7.1.1 Europe Tumor Multigene Detection Kit Sales by Country (2021-2026)
7.1.2 Europe Tumor Multigene Detection Kit Revenue by Country (2021-2026)
7.2 Europe Tumor Multigene Detection Kit Sales by Type (2021-2026)
7.3 Europe Tumor Multigene Detection Kit Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Tumor Multigene Detection Kit by Country
8.1.1 Middle East & Africa Tumor Multigene Detection Kit Sales by Country (2021-2026)
8.1.2 Middle East & Africa Tumor Multigene Detection Kit Revenue by Country (2021-2026)
8.2 Middle East & Africa Tumor Multigene Detection Kit Sales by Type (2021-2026)
8.3 Middle East & Africa Tumor Multigene Detection Kit Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Tumor Multigene Detection Kit
10.3 Manufacturing Process Analysis of Tumor Multigene Detection Kit
10.4 Industry Chain Structure of Tumor Multigene Detection Kit
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Tumor Multigene Detection Kit Distributors
11.3 Tumor Multigene Detection Kit Customer
12 WORLD FORECAST REVIEW FOR TUMOR MULTIGENE DETECTION KIT BY GEOGRAPHIC REGION
12.1 Global Tumor Multigene Detection Kit Market Size Forecast by Region
12.1.1 Global Tumor Multigene Detection Kit Forecast by Region (2027-2032)
12.1.2 Global Tumor Multigene Detection Kit Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Tumor Multigene Detection Kit Forecast by Type (2027-2032)
12.7 Global Tumor Multigene Detection Kit Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Roche Foundation Medicine
13.1.1 Roche Foundation Medicine Company Information
13.1.2 Roche Foundation Medicine Tumor Multigene Detection Kit Product Portfolios and Specifications
13.1.3 Roche Foundation Medicine Tumor Multigene Detection Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Roche Foundation Medicine Main Business Overview
13.1.5 Roche Foundation Medicine Latest Developments
13.2 Illumina Inc.
13.2.1 Illumina Inc. Company Information
13.2.2 Illumina Inc. Tumor Multigene Detection Kit Product Portfolios and Specifications
13.2.3 Illumina Inc. Tumor Multigene Detection Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Illumina Inc. Main Business Overview
13.2.5 Illumina Inc. Latest Developments
13.3 Life Technologies Corporation
13.3.1 Life Technologies Corporation Company Information
13.3.2 Life Technologies Corporation Tumor Multigene Detection Kit Product Portfolios and Specifications
13.3.3 Life Technologies Corporation Tumor Multigene Detection Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Life Technologies Corporation Main Business Overview
13.3.5 Life Technologies Corporation Latest Developments
13.4 Thermo Fisher Scientific
13.4.1 Thermo Fisher Scientific Company Information
13.4.2 Thermo Fisher Scientific Tumor Multigene Detection Kit Product Portfolios and Specifications
13.4.3 Thermo Fisher Scientific Tumor Multigene Detection Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Thermo Fisher Scientific Main Business Overview
13.4.5 Thermo Fisher Scientific Latest Developments
13.5 Memorial Sloan Kettering
13.5.1 Memorial Sloan Kettering Company Information
13.5.2 Memorial Sloan Kettering Tumor Multigene Detection Kit Product Portfolios and Specifications
13.5.3 Memorial Sloan Kettering Tumor Multigene Detection Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Memorial Sloan Kettering Main Business Overview
13.5.5 Memorial Sloan Kettering Latest Developments
13.6 Novogene
13.6.1 Novogene Company Information
13.6.2 Novogene Tumor Multigene Detection Kit Product Portfolios and Specifications
13.6.3 Novogene Tumor Multigene Detection Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Novogene Main Business Overview
13.6.5 Novogene Latest Developments
13.7 Geneseeq
13.7.1 Geneseeq Company Information
13.7.2 Geneseeq Tumor Multigene Detection Kit Product Portfolios and Specifications
13.7.3 Geneseeq Tumor Multigene Detection Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Geneseeq Main Business Overview
13.7.5 Geneseeq Latest Developments
13.8 AmoyDx
13.8.1 AmoyDx Company Information
13.8.2 AmoyDx Tumor Multigene Detection Kit Product Portfolios and Specifications
13.8.3 AmoyDx Tumor Multigene Detection Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 AmoyDx Main Business Overview
13.8.5 AmoyDx Latest Developments
13.9 Burning Rock Medicine
13.9.1 Burning Rock Medicine Company Information
13.9.2 Burning Rock Medicine Tumor Multigene Detection Kit Product Portfolios and Specifications
13.9.3 Burning Rock Medicine Tumor Multigene Detection Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Burning Rock Medicine Main Business Overview
13.9.5 Burning Rock Medicine Latest Developments
13.10 NantHealth
13.10.1 NantHealth Company Information
13.10.2 NantHealth Tumor Multigene Detection Kit Product Portfolios and Specifications
13.10.3 NantHealth Tumor Multigene Detection Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 NantHealth Main Business Overview
13.10.5 NantHealth Latest Developments
13.11 Personal Genome Diagnostics
13.11.1 Personal Genome Diagnostics Company Information
13.11.2 Personal Genome Diagnostics Tumor Multigene Detection Kit Product Portfolios and Specifications
13.11.3 Personal Genome Diagnostics Tumor Multigene Detection Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Personal Genome Diagnostics Main Business Overview
13.11.5 Personal Genome Diagnostics Latest Developments
13.12 GTH.O
13.12.1 GTH.O Company Information
13.12.2 GTH.O Tumor Multigene Detection Kit Product Portfolios and Specifications
13.12.3 GTH.O Tumor Multigene Detection Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 GTH.O Main Business Overview
13.12.5 GTH.O Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Tumor Multigene Detection Kit Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Tumor Multigene Detection Kit by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Tumor Multigene Detection Kit by Country/Region, 2021, 2025 & 2032
2.2 Tumor Multigene Detection Kit Segment by Type
2.2.1 Reversible End Termination Sequencing
2.2.2 Semiconductor Sequencing
2.2.3 Combined Probe Anchored Polymerization Sequencing
2.2.4 Tumor Multigene Detection Kit Sales by Type
2.2.4.1 Global Tumor Multigene Detection Kit Sales Market Share by Type (2021-2026)
2.2.4.2 Global Tumor Multigene Detection Kit Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Tumor Multigene Detection Kit Sale Price by Type (2021-2026)
2.3 Tumor Multigene Detection Kit Segment by Application
2.3.1 Companion Diagnostics
2.3.2 Early Cancer Screening
2.3.3 Drug Discovery
2.3.4 Other
2.3.5 Tumor Multigene Detection Kit Sales by Application
2.3.5.1 Global Tumor Multigene Detection Kit Sale Market Share by Application (2021-2026)
2.3.5.2 Global Tumor Multigene Detection Kit Revenue and Market Share by Application (2021-2026)
2.3.5.3 Global Tumor Multigene Detection Kit Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Tumor Multigene Detection Kit Breakdown Data by Company
3.1.1 Global Tumor Multigene Detection Kit Annual Sales by Company (2021-2026)
3.1.2 Global Tumor Multigene Detection Kit Sales Market Share by Company (2021-2026)
3.2 Global Tumor Multigene Detection Kit Annual Revenue by Company (2021-2026)
3.2.1 Global Tumor Multigene Detection Kit Revenue by Company (2021-2026)
3.2.2 Global Tumor Multigene Detection Kit Revenue Market Share by Company (2021-2026)
3.3 Global Tumor Multigene Detection Kit Sale Price by Company
3.4 Key Manufacturers Tumor Multigene Detection Kit Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Tumor Multigene Detection Kit Product Location Distribution
3.4.2 Players Tumor Multigene Detection Kit Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR TUMOR MULTIGENE DETECTION KIT BY GEOGRAPHIC REGION
4.1 World Historic Tumor Multigene Detection Kit Market Size by Geographic Region (2021-2026)
4.1.1 Global Tumor Multigene Detection Kit Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Tumor Multigene Detection Kit Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Tumor Multigene Detection Kit Market Size by Country/Region (2021-2026)
4.2.1 Global Tumor Multigene Detection Kit Annual Sales by Country/Region (2021-2026)
4.2.2 Global Tumor Multigene Detection Kit Annual Revenue by Country/Region (2021-2026)
4.3 Americas Tumor Multigene Detection Kit Sales Growth
4.4 APAC Tumor Multigene Detection Kit Sales Growth
4.5 Europe Tumor Multigene Detection Kit Sales Growth
4.6 Middle East & Africa Tumor Multigene Detection Kit Sales Growth
5 AMERICAS
5.1 Americas Tumor Multigene Detection Kit Sales by Country
5.1.1 Americas Tumor Multigene Detection Kit Sales by Country (2021-2026)
5.1.2 Americas Tumor Multigene Detection Kit Revenue by Country (2021-2026)
5.2 Americas Tumor Multigene Detection Kit Sales by Type (2021-2026)
5.3 Americas Tumor Multigene Detection Kit Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tumor Multigene Detection Kit Sales by Region
6.1.1 APAC Tumor Multigene Detection Kit Sales by Region (2021-2026)
6.1.2 APAC Tumor Multigene Detection Kit Revenue by Region (2021-2026)
6.2 APAC Tumor Multigene Detection Kit Sales by Type (2021-2026)
6.3 APAC Tumor Multigene Detection Kit Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Tumor Multigene Detection Kit by Country
7.1.1 Europe Tumor Multigene Detection Kit Sales by Country (2021-2026)
7.1.2 Europe Tumor Multigene Detection Kit Revenue by Country (2021-2026)
7.2 Europe Tumor Multigene Detection Kit Sales by Type (2021-2026)
7.3 Europe Tumor Multigene Detection Kit Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Tumor Multigene Detection Kit by Country
8.1.1 Middle East & Africa Tumor Multigene Detection Kit Sales by Country (2021-2026)
8.1.2 Middle East & Africa Tumor Multigene Detection Kit Revenue by Country (2021-2026)
8.2 Middle East & Africa Tumor Multigene Detection Kit Sales by Type (2021-2026)
8.3 Middle East & Africa Tumor Multigene Detection Kit Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Tumor Multigene Detection Kit
10.3 Manufacturing Process Analysis of Tumor Multigene Detection Kit
10.4 Industry Chain Structure of Tumor Multigene Detection Kit
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Tumor Multigene Detection Kit Distributors
11.3 Tumor Multigene Detection Kit Customer
12 WORLD FORECAST REVIEW FOR TUMOR MULTIGENE DETECTION KIT BY GEOGRAPHIC REGION
12.1 Global Tumor Multigene Detection Kit Market Size Forecast by Region
12.1.1 Global Tumor Multigene Detection Kit Forecast by Region (2027-2032)
12.1.2 Global Tumor Multigene Detection Kit Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Tumor Multigene Detection Kit Forecast by Type (2027-2032)
12.7 Global Tumor Multigene Detection Kit Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Roche Foundation Medicine
13.1.1 Roche Foundation Medicine Company Information
13.1.2 Roche Foundation Medicine Tumor Multigene Detection Kit Product Portfolios and Specifications
13.1.3 Roche Foundation Medicine Tumor Multigene Detection Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Roche Foundation Medicine Main Business Overview
13.1.5 Roche Foundation Medicine Latest Developments
13.2 Illumina Inc.
13.2.1 Illumina Inc. Company Information
13.2.2 Illumina Inc. Tumor Multigene Detection Kit Product Portfolios and Specifications
13.2.3 Illumina Inc. Tumor Multigene Detection Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Illumina Inc. Main Business Overview
13.2.5 Illumina Inc. Latest Developments
13.3 Life Technologies Corporation
13.3.1 Life Technologies Corporation Company Information
13.3.2 Life Technologies Corporation Tumor Multigene Detection Kit Product Portfolios and Specifications
13.3.3 Life Technologies Corporation Tumor Multigene Detection Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Life Technologies Corporation Main Business Overview
13.3.5 Life Technologies Corporation Latest Developments
13.4 Thermo Fisher Scientific
13.4.1 Thermo Fisher Scientific Company Information
13.4.2 Thermo Fisher Scientific Tumor Multigene Detection Kit Product Portfolios and Specifications
13.4.3 Thermo Fisher Scientific Tumor Multigene Detection Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Thermo Fisher Scientific Main Business Overview
13.4.5 Thermo Fisher Scientific Latest Developments
13.5 Memorial Sloan Kettering
13.5.1 Memorial Sloan Kettering Company Information
13.5.2 Memorial Sloan Kettering Tumor Multigene Detection Kit Product Portfolios and Specifications
13.5.3 Memorial Sloan Kettering Tumor Multigene Detection Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Memorial Sloan Kettering Main Business Overview
13.5.5 Memorial Sloan Kettering Latest Developments
13.6 Novogene
13.6.1 Novogene Company Information
13.6.2 Novogene Tumor Multigene Detection Kit Product Portfolios and Specifications
13.6.3 Novogene Tumor Multigene Detection Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Novogene Main Business Overview
13.6.5 Novogene Latest Developments
13.7 Geneseeq
13.7.1 Geneseeq Company Information
13.7.2 Geneseeq Tumor Multigene Detection Kit Product Portfolios and Specifications
13.7.3 Geneseeq Tumor Multigene Detection Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Geneseeq Main Business Overview
13.7.5 Geneseeq Latest Developments
13.8 AmoyDx
13.8.1 AmoyDx Company Information
13.8.2 AmoyDx Tumor Multigene Detection Kit Product Portfolios and Specifications
13.8.3 AmoyDx Tumor Multigene Detection Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 AmoyDx Main Business Overview
13.8.5 AmoyDx Latest Developments
13.9 Burning Rock Medicine
13.9.1 Burning Rock Medicine Company Information
13.9.2 Burning Rock Medicine Tumor Multigene Detection Kit Product Portfolios and Specifications
13.9.3 Burning Rock Medicine Tumor Multigene Detection Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Burning Rock Medicine Main Business Overview
13.9.5 Burning Rock Medicine Latest Developments
13.10 NantHealth
13.10.1 NantHealth Company Information
13.10.2 NantHealth Tumor Multigene Detection Kit Product Portfolios and Specifications
13.10.3 NantHealth Tumor Multigene Detection Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 NantHealth Main Business Overview
13.10.5 NantHealth Latest Developments
13.11 Personal Genome Diagnostics
13.11.1 Personal Genome Diagnostics Company Information
13.11.2 Personal Genome Diagnostics Tumor Multigene Detection Kit Product Portfolios and Specifications
13.11.3 Personal Genome Diagnostics Tumor Multigene Detection Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Personal Genome Diagnostics Main Business Overview
13.11.5 Personal Genome Diagnostics Latest Developments
13.12 GTH.O
13.12.1 GTH.O Company Information
13.12.2 GTH.O Tumor Multigene Detection Kit Product Portfolios and Specifications
13.12.3 GTH.O Tumor Multigene Detection Kit Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 GTH.O Main Business Overview
13.12.5 GTH.O Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Tumor Multigene Detection Kit Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Tumor Multigene Detection Kit Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Reversible End Termination Sequencing
Table 4. Major Players of Semiconductor Sequencing
Table 5. Major Players of Combined Probe Anchored Polymerization Sequencing
Table 6. Global Tumor Multigene Detection Kit Sales by Type (2021-2026) & (K Units)
Table 7. Global Tumor Multigene Detection Kit Sales Market Share by Type (2021-2026)
Table 8. Global Tumor Multigene Detection Kit Revenue by Type (2021-2026) & ($ million)
Table 9. Global Tumor Multigene Detection Kit Revenue Market Share by Type (2021-2026)
Table 10. Global Tumor Multigene Detection Kit Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Tumor Multigene Detection Kit Sale by Application (2021-2026) & (K Units)
Table 12. Global Tumor Multigene Detection Kit Sale Market Share by Application (2021-2026)
Table 13. Global Tumor Multigene Detection Kit Revenue by Application (2021-2026) & ($ million)
Table 14. Global Tumor Multigene Detection Kit Revenue Market Share by Application (2021-2026)
Table 15. Global Tumor Multigene Detection Kit Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Tumor Multigene Detection Kit Sales by Company (2021-2026) & (K Units)
Table 17. Global Tumor Multigene Detection Kit Sales Market Share by Company (2021-2026)
Table 18. Global Tumor Multigene Detection Kit Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Tumor Multigene Detection Kit Revenue Market Share by Company (2021-2026)
Table 20. Global Tumor Multigene Detection Kit Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Tumor Multigene Detection Kit Producing Area Distribution and Sales Area
Table 22. Players Tumor Multigene Detection Kit Products Offered
Table 23. Tumor Multigene Detection Kit Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Tumor Multigene Detection Kit Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global Tumor Multigene Detection Kit Sales Market Share Geographic Region (2021-2026)
Table 28. Global Tumor Multigene Detection Kit Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Tumor Multigene Detection Kit Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Tumor Multigene Detection Kit Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global Tumor Multigene Detection Kit Sales Market Share by Country/Region (2021-2026)
Table 32. Global Tumor Multigene Detection Kit Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Tumor Multigene Detection Kit Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Tumor Multigene Detection Kit Sales by Country (2021-2026) & (K Units)
Table 35. Americas Tumor Multigene Detection Kit Sales Market Share by Country (2021-2026)
Table 36. Americas Tumor Multigene Detection Kit Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Tumor Multigene Detection Kit Sales by Type (2021-2026) & (K Units)
Table 38. Americas Tumor Multigene Detection Kit Sales by Application (2021-2026) & (K Units)
Table 39. APAC Tumor Multigene Detection Kit Sales by Region (2021-2026) & (K Units)
Table 40. APAC Tumor Multigene Detection Kit Sales Market Share by Region (2021-2026)
Table 41. APAC Tumor Multigene Detection Kit Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Tumor Multigene Detection Kit Sales by Type (2021-2026) & (K Units)
Table 43. APAC Tumor Multigene Detection Kit Sales by Application (2021-2026) & (K Units)
Table 44. Europe Tumor Multigene Detection Kit Sales by Country (2021-2026) & (K Units)
Table 45. Europe Tumor Multigene Detection Kit Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Tumor Multigene Detection Kit Sales by Type (2021-2026) & (K Units)
Table 47. Europe Tumor Multigene Detection Kit Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa Tumor Multigene Detection Kit Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa Tumor Multigene Detection Kit Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Tumor Multigene Detection Kit Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa Tumor Multigene Detection Kit Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Tumor Multigene Detection Kit
Table 53. Key Market Challenges & Risks of Tumor Multigene Detection Kit
Table 54. Key Industry Trends of Tumor Multigene Detection Kit
Table 55. Tumor Multigene Detection Kit Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Tumor Multigene Detection Kit Distributors List
Table 58. Tumor Multigene Detection Kit Customer List
Table 59. Global Tumor Multigene Detection Kit Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global Tumor Multigene Detection Kit Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Tumor Multigene Detection Kit Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas Tumor Multigene Detection Kit Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Tumor Multigene Detection Kit Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC Tumor Multigene Detection Kit Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Tumor Multigene Detection Kit Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe Tumor Multigene Detection Kit Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Tumor Multigene Detection Kit Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa Tumor Multigene Detection Kit Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Tumor Multigene Detection Kit Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global Tumor Multigene Detection Kit Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Tumor Multigene Detection Kit Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global Tumor Multigene Detection Kit Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Roche Foundation Medicine Basic Information, Tumor Multigene Detection Kit Manufacturing Base, Sales Area and Its Competitors
Table 74. Roche Foundation Medicine Tumor Multigene Detection Kit Product Portfolios and Specifications
Table 75. Roche Foundation Medicine Tumor Multigene Detection Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Roche Foundation Medicine Main Business
Table 77. Roche Foundation Medicine Latest Developments
Table 78. Illumina Inc. Basic Information, Tumor Multigene Detection Kit Manufacturing Base, Sales Area and Its Competitors
Table 79. Illumina Inc. Tumor Multigene Detection Kit Product Portfolios and Specifications
Table 80. Illumina Inc. Tumor Multigene Detection Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Illumina Inc. Main Business
Table 82. Illumina Inc. Latest Developments
Table 83. Life Technologies Corporation Basic Information, Tumor Multigene Detection Kit Manufacturing Base, Sales Area and Its Competitors
Table 84. Life Technologies Corporation Tumor Multigene Detection Kit Product Portfolios and Specifications
Table 85. Life Technologies Corporation Tumor Multigene Detection Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Life Technologies Corporation Main Business
Table 87. Life Technologies Corporation Latest Developments
Table 88. Thermo Fisher Scientific Basic Information, Tumor Multigene Detection Kit Manufacturing Base, Sales Area and Its Competitors
Table 89. Thermo Fisher Scientific Tumor Multigene Detection Kit Product Portfolios and Specifications
Table 90. Thermo Fisher Scientific Tumor Multigene Detection Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Thermo Fisher Scientific Main Business
Table 92. Thermo Fisher Scientific Latest Developments
Table 93. Memorial Sloan Kettering Basic Information, Tumor Multigene Detection Kit Manufacturing Base, Sales Area and Its Competitors
Table 94. Memorial Sloan Kettering Tumor Multigene Detection Kit Product Portfolios and Specifications
Table 95. Memorial Sloan Kettering Tumor Multigene Detection Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Memorial Sloan Kettering Main Business
Table 97. Memorial Sloan Kettering Latest Developments
Table 98. Novogene Basic Information, Tumor Multigene Detection Kit Manufacturing Base, Sales Area and Its Competitors
Table 99. Novogene Tumor Multigene Detection Kit Product Portfolios and Specifications
Table 100. Novogene Tumor Multigene Detection Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Novogene Main Business
Table 102. Novogene Latest Developments
Table 103. Geneseeq Basic Information, Tumor Multigene Detection Kit Manufacturing Base, Sales Area and Its Competitors
Table 104. Geneseeq Tumor Multigene Detection Kit Product Portfolios and Specifications
Table 105. Geneseeq Tumor Multigene Detection Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Geneseeq Main Business
Table 107. Geneseeq Latest Developments
Table 108. AmoyDx Basic Information, Tumor Multigene Detection Kit Manufacturing Base, Sales Area and Its Competitors
Table 109. AmoyDx Tumor Multigene Detection Kit Product Portfolios and Specifications
Table 110. AmoyDx Tumor Multigene Detection Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. AmoyDx Main Business
Table 112. AmoyDx Latest Developments
Table 113. Burning Rock Medicine Basic Information, Tumor Multigene Detection Kit Manufacturing Base, Sales Area and Its Competitors
Table 114. Burning Rock Medicine Tumor Multigene Detection Kit Product Portfolios and Specifications
Table 115. Burning Rock Medicine Tumor Multigene Detection Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Burning Rock Medicine Main Business
Table 117. Burning Rock Medicine Latest Developments
Table 118. NantHealth Basic Information, Tumor Multigene Detection Kit Manufacturing Base, Sales Area and Its Competitors
Table 119. NantHealth Tumor Multigene Detection Kit Product Portfolios and Specifications
Table 120. NantHealth Tumor Multigene Detection Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. NantHealth Main Business
Table 122. NantHealth Latest Developments
Table 123. Personal Genome Diagnostics Basic Information, Tumor Multigene Detection Kit Manufacturing Base, Sales Area and Its Competitors
Table 124. Personal Genome Diagnostics Tumor Multigene Detection Kit Product Portfolios and Specifications
Table 125. Personal Genome Diagnostics Tumor Multigene Detection Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Personal Genome Diagnostics Main Business
Table 127. Personal Genome Diagnostics Latest Developments
Table 128. GTH.O Basic Information, Tumor Multigene Detection Kit Manufacturing Base, Sales Area and Its Competitors
Table 129. GTH.O Tumor Multigene Detection Kit Product Portfolios and Specifications
Table 130. GTH.O Tumor Multigene Detection Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. GTH.O Main Business
Table 132. GTH.O Latest Developments
Table 1. Tumor Multigene Detection Kit Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Tumor Multigene Detection Kit Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Reversible End Termination Sequencing
Table 4. Major Players of Semiconductor Sequencing
Table 5. Major Players of Combined Probe Anchored Polymerization Sequencing
Table 6. Global Tumor Multigene Detection Kit Sales by Type (2021-2026) & (K Units)
Table 7. Global Tumor Multigene Detection Kit Sales Market Share by Type (2021-2026)
Table 8. Global Tumor Multigene Detection Kit Revenue by Type (2021-2026) & ($ million)
Table 9. Global Tumor Multigene Detection Kit Revenue Market Share by Type (2021-2026)
Table 10. Global Tumor Multigene Detection Kit Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Tumor Multigene Detection Kit Sale by Application (2021-2026) & (K Units)
Table 12. Global Tumor Multigene Detection Kit Sale Market Share by Application (2021-2026)
Table 13. Global Tumor Multigene Detection Kit Revenue by Application (2021-2026) & ($ million)
Table 14. Global Tumor Multigene Detection Kit Revenue Market Share by Application (2021-2026)
Table 15. Global Tumor Multigene Detection Kit Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Tumor Multigene Detection Kit Sales by Company (2021-2026) & (K Units)
Table 17. Global Tumor Multigene Detection Kit Sales Market Share by Company (2021-2026)
Table 18. Global Tumor Multigene Detection Kit Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Tumor Multigene Detection Kit Revenue Market Share by Company (2021-2026)
Table 20. Global Tumor Multigene Detection Kit Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Tumor Multigene Detection Kit Producing Area Distribution and Sales Area
Table 22. Players Tumor Multigene Detection Kit Products Offered
Table 23. Tumor Multigene Detection Kit Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Tumor Multigene Detection Kit Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global Tumor Multigene Detection Kit Sales Market Share Geographic Region (2021-2026)
Table 28. Global Tumor Multigene Detection Kit Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Tumor Multigene Detection Kit Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Tumor Multigene Detection Kit Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global Tumor Multigene Detection Kit Sales Market Share by Country/Region (2021-2026)
Table 32. Global Tumor Multigene Detection Kit Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Tumor Multigene Detection Kit Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Tumor Multigene Detection Kit Sales by Country (2021-2026) & (K Units)
Table 35. Americas Tumor Multigene Detection Kit Sales Market Share by Country (2021-2026)
Table 36. Americas Tumor Multigene Detection Kit Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Tumor Multigene Detection Kit Sales by Type (2021-2026) & (K Units)
Table 38. Americas Tumor Multigene Detection Kit Sales by Application (2021-2026) & (K Units)
Table 39. APAC Tumor Multigene Detection Kit Sales by Region (2021-2026) & (K Units)
Table 40. APAC Tumor Multigene Detection Kit Sales Market Share by Region (2021-2026)
Table 41. APAC Tumor Multigene Detection Kit Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Tumor Multigene Detection Kit Sales by Type (2021-2026) & (K Units)
Table 43. APAC Tumor Multigene Detection Kit Sales by Application (2021-2026) & (K Units)
Table 44. Europe Tumor Multigene Detection Kit Sales by Country (2021-2026) & (K Units)
Table 45. Europe Tumor Multigene Detection Kit Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Tumor Multigene Detection Kit Sales by Type (2021-2026) & (K Units)
Table 47. Europe Tumor Multigene Detection Kit Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa Tumor Multigene Detection Kit Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa Tumor Multigene Detection Kit Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Tumor Multigene Detection Kit Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa Tumor Multigene Detection Kit Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Tumor Multigene Detection Kit
Table 53. Key Market Challenges & Risks of Tumor Multigene Detection Kit
Table 54. Key Industry Trends of Tumor Multigene Detection Kit
Table 55. Tumor Multigene Detection Kit Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Tumor Multigene Detection Kit Distributors List
Table 58. Tumor Multigene Detection Kit Customer List
Table 59. Global Tumor Multigene Detection Kit Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global Tumor Multigene Detection Kit Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Tumor Multigene Detection Kit Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas Tumor Multigene Detection Kit Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Tumor Multigene Detection Kit Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC Tumor Multigene Detection Kit Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Tumor Multigene Detection Kit Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe Tumor Multigene Detection Kit Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Tumor Multigene Detection Kit Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa Tumor Multigene Detection Kit Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Tumor Multigene Detection Kit Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global Tumor Multigene Detection Kit Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Tumor Multigene Detection Kit Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global Tumor Multigene Detection Kit Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Roche Foundation Medicine Basic Information, Tumor Multigene Detection Kit Manufacturing Base, Sales Area and Its Competitors
Table 74. Roche Foundation Medicine Tumor Multigene Detection Kit Product Portfolios and Specifications
Table 75. Roche Foundation Medicine Tumor Multigene Detection Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Roche Foundation Medicine Main Business
Table 77. Roche Foundation Medicine Latest Developments
Table 78. Illumina Inc. Basic Information, Tumor Multigene Detection Kit Manufacturing Base, Sales Area and Its Competitors
Table 79. Illumina Inc. Tumor Multigene Detection Kit Product Portfolios and Specifications
Table 80. Illumina Inc. Tumor Multigene Detection Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Illumina Inc. Main Business
Table 82. Illumina Inc. Latest Developments
Table 83. Life Technologies Corporation Basic Information, Tumor Multigene Detection Kit Manufacturing Base, Sales Area and Its Competitors
Table 84. Life Technologies Corporation Tumor Multigene Detection Kit Product Portfolios and Specifications
Table 85. Life Technologies Corporation Tumor Multigene Detection Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Life Technologies Corporation Main Business
Table 87. Life Technologies Corporation Latest Developments
Table 88. Thermo Fisher Scientific Basic Information, Tumor Multigene Detection Kit Manufacturing Base, Sales Area and Its Competitors
Table 89. Thermo Fisher Scientific Tumor Multigene Detection Kit Product Portfolios and Specifications
Table 90. Thermo Fisher Scientific Tumor Multigene Detection Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Thermo Fisher Scientific Main Business
Table 92. Thermo Fisher Scientific Latest Developments
Table 93. Memorial Sloan Kettering Basic Information, Tumor Multigene Detection Kit Manufacturing Base, Sales Area and Its Competitors
Table 94. Memorial Sloan Kettering Tumor Multigene Detection Kit Product Portfolios and Specifications
Table 95. Memorial Sloan Kettering Tumor Multigene Detection Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Memorial Sloan Kettering Main Business
Table 97. Memorial Sloan Kettering Latest Developments
Table 98. Novogene Basic Information, Tumor Multigene Detection Kit Manufacturing Base, Sales Area and Its Competitors
Table 99. Novogene Tumor Multigene Detection Kit Product Portfolios and Specifications
Table 100. Novogene Tumor Multigene Detection Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Novogene Main Business
Table 102. Novogene Latest Developments
Table 103. Geneseeq Basic Information, Tumor Multigene Detection Kit Manufacturing Base, Sales Area and Its Competitors
Table 104. Geneseeq Tumor Multigene Detection Kit Product Portfolios and Specifications
Table 105. Geneseeq Tumor Multigene Detection Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Geneseeq Main Business
Table 107. Geneseeq Latest Developments
Table 108. AmoyDx Basic Information, Tumor Multigene Detection Kit Manufacturing Base, Sales Area and Its Competitors
Table 109. AmoyDx Tumor Multigene Detection Kit Product Portfolios and Specifications
Table 110. AmoyDx Tumor Multigene Detection Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. AmoyDx Main Business
Table 112. AmoyDx Latest Developments
Table 113. Burning Rock Medicine Basic Information, Tumor Multigene Detection Kit Manufacturing Base, Sales Area and Its Competitors
Table 114. Burning Rock Medicine Tumor Multigene Detection Kit Product Portfolios and Specifications
Table 115. Burning Rock Medicine Tumor Multigene Detection Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Burning Rock Medicine Main Business
Table 117. Burning Rock Medicine Latest Developments
Table 118. NantHealth Basic Information, Tumor Multigene Detection Kit Manufacturing Base, Sales Area and Its Competitors
Table 119. NantHealth Tumor Multigene Detection Kit Product Portfolios and Specifications
Table 120. NantHealth Tumor Multigene Detection Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. NantHealth Main Business
Table 122. NantHealth Latest Developments
Table 123. Personal Genome Diagnostics Basic Information, Tumor Multigene Detection Kit Manufacturing Base, Sales Area and Its Competitors
Table 124. Personal Genome Diagnostics Tumor Multigene Detection Kit Product Portfolios and Specifications
Table 125. Personal Genome Diagnostics Tumor Multigene Detection Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Personal Genome Diagnostics Main Business
Table 127. Personal Genome Diagnostics Latest Developments
Table 128. GTH.O Basic Information, Tumor Multigene Detection Kit Manufacturing Base, Sales Area and Its Competitors
Table 129. GTH.O Tumor Multigene Detection Kit Product Portfolios and Specifications
Table 130. GTH.O Tumor Multigene Detection Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. GTH.O Main Business
Table 132. GTH.O Latest Developments
LIST OF FIGURES
Figure 1. Picture of Tumor Multigene Detection Kit
Figure 2. Tumor Multigene Detection Kit Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Tumor Multigene Detection Kit Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Tumor Multigene Detection Kit Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Tumor Multigene Detection Kit Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Tumor Multigene Detection Kit Sales Market Share by Country/Region (2025)
Figure 10. Tumor Multigene Detection Kit Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Reversible End Termination Sequencing
Figure 12. Product Picture of Semiconductor Sequencing
Figure 13. Product Picture of Combined Probe Anchored Polymerization Sequencing
Figure 14. Global Tumor Multigene Detection Kit Sales Market Share by Type in 2026
Figure 15. Global Tumor Multigene Detection Kit Revenue Market Share by Type (2021-2026)
Figure 16. Tumor Multigene Detection Kit Consumed in Companion Diagnostics
Figure 17. Global Tumor Multigene Detection Kit Market: Companion Diagnostics (2021-2026) & (K Units)
Figure 18. Tumor Multigene Detection Kit Consumed in Early Cancer Screening
Figure 19. Global Tumor Multigene Detection Kit Market: Early Cancer Screening (2021-2026) & (K Units)
Figure 20. Tumor Multigene Detection Kit Consumed in Drug Discovery
Figure 21. Global Tumor Multigene Detection Kit Market: Drug Discovery (2021-2026) & (K Units)
Figure 22. Tumor Multigene Detection Kit Consumed in Other
Figure 23. Global Tumor Multigene Detection Kit Market: Other (2021-2026) & (K Units)
Figure 24. Global Tumor Multigene Detection Kit Sale Market Share by Application (2025)
Figure 25. Global Tumor Multigene Detection Kit Revenue Market Share by Application in 2026
Figure 26. Tumor Multigene Detection Kit Sales by Company in 2026 (K Units)
Figure 27. Global Tumor Multigene Detection Kit Sales Market Share by Company in 2026
Figure 28. Tumor Multigene Detection Kit Revenue by Company in 2026 ($ millions)
Figure 29. Global Tumor Multigene Detection Kit Revenue Market Share by Company in 2026
Figure 30. Global Tumor Multigene Detection Kit Sales Market Share by Geographic Region (2021-2026)
Figure 31. Global Tumor Multigene Detection Kit Revenue Market Share by Geographic Region in 2026
Figure 32. Americas Tumor Multigene Detection Kit Sales 2021-2026 (K Units)
Figure 33. Americas Tumor Multigene Detection Kit Revenue 2021-2026 ($ millions)
Figure 34. APAC Tumor Multigene Detection Kit Sales 2021-2026 (K Units)
Figure 35. APAC Tumor Multigene Detection Kit Revenue 2021-2026 ($ millions)
Figure 36. Europe Tumor Multigene Detection Kit Sales 2021-2026 (K Units)
Figure 37. Europe Tumor Multigene Detection Kit Revenue 2021-2026 ($ millions)
Figure 38. Middle East & Africa Tumor Multigene Detection Kit Sales 2021-2026 (K Units)
Figure 39. Middle East & Africa Tumor Multigene Detection Kit Revenue 2021-2026 ($ millions)
Figure 40. Americas Tumor Multigene Detection Kit Sales Market Share by Country in 2026
Figure 41. Americas Tumor Multigene Detection Kit Revenue Market Share by Country (2021-2026)
Figure 42. Americas Tumor Multigene Detection Kit Sales Market Share by Type (2021-2026)
Figure 43. Americas Tumor Multigene Detection Kit Sales Market Share by Application (2021-2026)
Figure 44. United States Tumor Multigene Detection Kit Revenue Growth 2021-2026 ($ millions)
Figure 45. Canada Tumor Multigene Detection Kit Revenue Growth 2021-2026 ($ millions)
Figure 46. Mexico Tumor Multigene Detection Kit Revenue Growth 2021-2026 ($ millions)
Figure 47. Brazil Tumor Multigene Detection Kit Revenue Growth 2021-2026 ($ millions)
Figure 48. APAC Tumor Multigene Detection Kit Sales Market Share by Region in 2026
Figure 49. APAC Tumor Multigene Detection Kit Revenue Market Share by Region (2021-2026)
Figure 50. APAC Tumor Multigene Detection Kit Sales Market Share by Type (2021-2026)
Figure 51. APAC Tumor Multigene Detection Kit Sales Market Share by Application (2021-2026)
Figure 52. China Tumor Multigene Detection Kit Revenue Growth 2021-2026 ($ millions)
Figure 53. Japan Tumor Multigene Detection Kit Revenue Growth 2021-2026 ($ millions)
Figure 54. South Korea Tumor Multigene Detection Kit Revenue Growth 2021-2026 ($ millions)
Figure 55. Southeast Asia Tumor Multigene Detection Kit Revenue Growth 2021-2026 ($ millions)
Figure 56. India Tumor Multigene Detection Kit Revenue Growth 2021-2026 ($ millions)
Figure 57. Australia Tumor Multigene Detection Kit Revenue Growth 2021-2026 ($ millions)
Figure 58. China Taiwan Tumor Multigene Detection Kit Revenue Growth 2021-2026 ($ millions)
Figure 59. Europe Tumor Multigene Detection Kit Sales Market Share by Country in 2026
Figure 60. Europe Tumor Multigene Detection Kit Revenue Market Share by Country (2021-2026)
Figure 61. Europe Tumor Multigene Detection Kit Sales Market Share by Type (2021-2026)
Figure 62. Europe Tumor Multigene Detection Kit Sales Market Share by Application (2021-2026)
Figure 63. Germany Tumor Multigene Detection Kit Revenue Growth 2021-2026 ($ millions)
Figure 64. France Tumor Multigene Detection Kit Revenue Growth 2021-2026 ($ millions)
Figure 65. UK Tumor Multigene Detection Kit Revenue Growth 2021-2026 ($ millions)
Figure 66. Italy Tumor Multigene Detection Kit Revenue Growth 2021-2026 ($ millions)
Figure 67. Russia Tumor Multigene Detection Kit Revenue Growth 2021-2026 ($ millions)
Figure 68. Middle East & Africa Tumor Multigene Detection Kit Sales Market Share by Country (2021-2026)
Figure 69. Middle East & Africa Tumor Multigene Detection Kit Sales Market Share by Type (2021-2026)
Figure 70. Middle East & Africa Tumor Multigene Detection Kit Sales Market Share by Application (2021-2026)
Figure 71. Egypt Tumor Multigene Detection Kit Revenue Growth 2021-2026 ($ millions)
Figure 72. South Africa Tumor Multigene Detection Kit Revenue Growth 2021-2026 ($ millions)
Figure 73. Israel Tumor Multigene Detection Kit Revenue Growth 2021-2026 ($ millions)
Figure 74. Turkey Tumor Multigene Detection Kit Revenue Growth 2021-2026 ($ millions)
Figure 75. GCC Countries Tumor Multigene Detection Kit Revenue Growth 2021-2026 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of Tumor Multigene Detection Kit in 2026
Figure 77. Manufacturing Process Analysis of Tumor Multigene Detection Kit
Figure 78. Industry Chain Structure of Tumor Multigene Detection Kit
Figure 79. Channels of Distribution
Figure 80. Global Tumor Multigene Detection Kit Sales Market Forecast by Region (2027-2032)
Figure 81. Global Tumor Multigene Detection Kit Revenue Market Share Forecast by Region (2027-2032)
Figure 82. Global Tumor Multigene Detection Kit Sales Market Share Forecast by Type (2027-2032)
Figure 83. Global Tumor Multigene Detection Kit Revenue Market Share Forecast by Type (2027-2032)
Figure 84. Global Tumor Multigene Detection Kit Sales Market Share Forecast by Application (2027-2032)
Figure 85. Global Tumor Multigene Detection Kit Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Tumor Multigene Detection Kit
Figure 2. Tumor Multigene Detection Kit Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Tumor Multigene Detection Kit Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Tumor Multigene Detection Kit Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Tumor Multigene Detection Kit Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Tumor Multigene Detection Kit Sales Market Share by Country/Region (2025)
Figure 10. Tumor Multigene Detection Kit Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Reversible End Termination Sequencing
Figure 12. Product Picture of Semiconductor Sequencing
Figure 13. Product Picture of Combined Probe Anchored Polymerization Sequencing
Figure 14. Global Tumor Multigene Detection Kit Sales Market Share by Type in 2026
Figure 15. Global Tumor Multigene Detection Kit Revenue Market Share by Type (2021-2026)
Figure 16. Tumor Multigene Detection Kit Consumed in Companion Diagnostics
Figure 17. Global Tumor Multigene Detection Kit Market: Companion Diagnostics (2021-2026) & (K Units)
Figure 18. Tumor Multigene Detection Kit Consumed in Early Cancer Screening
Figure 19. Global Tumor Multigene Detection Kit Market: Early Cancer Screening (2021-2026) & (K Units)
Figure 20. Tumor Multigene Detection Kit Consumed in Drug Discovery
Figure 21. Global Tumor Multigene Detection Kit Market: Drug Discovery (2021-2026) & (K Units)
Figure 22. Tumor Multigene Detection Kit Consumed in Other
Figure 23. Global Tumor Multigene Detection Kit Market: Other (2021-2026) & (K Units)
Figure 24. Global Tumor Multigene Detection Kit Sale Market Share by Application (2025)
Figure 25. Global Tumor Multigene Detection Kit Revenue Market Share by Application in 2026
Figure 26. Tumor Multigene Detection Kit Sales by Company in 2026 (K Units)
Figure 27. Global Tumor Multigene Detection Kit Sales Market Share by Company in 2026
Figure 28. Tumor Multigene Detection Kit Revenue by Company in 2026 ($ millions)
Figure 29. Global Tumor Multigene Detection Kit Revenue Market Share by Company in 2026
Figure 30. Global Tumor Multigene Detection Kit Sales Market Share by Geographic Region (2021-2026)
Figure 31. Global Tumor Multigene Detection Kit Revenue Market Share by Geographic Region in 2026
Figure 32. Americas Tumor Multigene Detection Kit Sales 2021-2026 (K Units)
Figure 33. Americas Tumor Multigene Detection Kit Revenue 2021-2026 ($ millions)
Figure 34. APAC Tumor Multigene Detection Kit Sales 2021-2026 (K Units)
Figure 35. APAC Tumor Multigene Detection Kit Revenue 2021-2026 ($ millions)
Figure 36. Europe Tumor Multigene Detection Kit Sales 2021-2026 (K Units)
Figure 37. Europe Tumor Multigene Detection Kit Revenue 2021-2026 ($ millions)
Figure 38. Middle East & Africa Tumor Multigene Detection Kit Sales 2021-2026 (K Units)
Figure 39. Middle East & Africa Tumor Multigene Detection Kit Revenue 2021-2026 ($ millions)
Figure 40. Americas Tumor Multigene Detection Kit Sales Market Share by Country in 2026
Figure 41. Americas Tumor Multigene Detection Kit Revenue Market Share by Country (2021-2026)
Figure 42. Americas Tumor Multigene Detection Kit Sales Market Share by Type (2021-2026)
Figure 43. Americas Tumor Multigene Detection Kit Sales Market Share by Application (2021-2026)
Figure 44. United States Tumor Multigene Detection Kit Revenue Growth 2021-2026 ($ millions)
Figure 45. Canada Tumor Multigene Detection Kit Revenue Growth 2021-2026 ($ millions)
Figure 46. Mexico Tumor Multigene Detection Kit Revenue Growth 2021-2026 ($ millions)
Figure 47. Brazil Tumor Multigene Detection Kit Revenue Growth 2021-2026 ($ millions)
Figure 48. APAC Tumor Multigene Detection Kit Sales Market Share by Region in 2026
Figure 49. APAC Tumor Multigene Detection Kit Revenue Market Share by Region (2021-2026)
Figure 50. APAC Tumor Multigene Detection Kit Sales Market Share by Type (2021-2026)
Figure 51. APAC Tumor Multigene Detection Kit Sales Market Share by Application (2021-2026)
Figure 52. China Tumor Multigene Detection Kit Revenue Growth 2021-2026 ($ millions)
Figure 53. Japan Tumor Multigene Detection Kit Revenue Growth 2021-2026 ($ millions)
Figure 54. South Korea Tumor Multigene Detection Kit Revenue Growth 2021-2026 ($ millions)
Figure 55. Southeast Asia Tumor Multigene Detection Kit Revenue Growth 2021-2026 ($ millions)
Figure 56. India Tumor Multigene Detection Kit Revenue Growth 2021-2026 ($ millions)
Figure 57. Australia Tumor Multigene Detection Kit Revenue Growth 2021-2026 ($ millions)
Figure 58. China Taiwan Tumor Multigene Detection Kit Revenue Growth 2021-2026 ($ millions)
Figure 59. Europe Tumor Multigene Detection Kit Sales Market Share by Country in 2026
Figure 60. Europe Tumor Multigene Detection Kit Revenue Market Share by Country (2021-2026)
Figure 61. Europe Tumor Multigene Detection Kit Sales Market Share by Type (2021-2026)
Figure 62. Europe Tumor Multigene Detection Kit Sales Market Share by Application (2021-2026)
Figure 63. Germany Tumor Multigene Detection Kit Revenue Growth 2021-2026 ($ millions)
Figure 64. France Tumor Multigene Detection Kit Revenue Growth 2021-2026 ($ millions)
Figure 65. UK Tumor Multigene Detection Kit Revenue Growth 2021-2026 ($ millions)
Figure 66. Italy Tumor Multigene Detection Kit Revenue Growth 2021-2026 ($ millions)
Figure 67. Russia Tumor Multigene Detection Kit Revenue Growth 2021-2026 ($ millions)
Figure 68. Middle East & Africa Tumor Multigene Detection Kit Sales Market Share by Country (2021-2026)
Figure 69. Middle East & Africa Tumor Multigene Detection Kit Sales Market Share by Type (2021-2026)
Figure 70. Middle East & Africa Tumor Multigene Detection Kit Sales Market Share by Application (2021-2026)
Figure 71. Egypt Tumor Multigene Detection Kit Revenue Growth 2021-2026 ($ millions)
Figure 72. South Africa Tumor Multigene Detection Kit Revenue Growth 2021-2026 ($ millions)
Figure 73. Israel Tumor Multigene Detection Kit Revenue Growth 2021-2026 ($ millions)
Figure 74. Turkey Tumor Multigene Detection Kit Revenue Growth 2021-2026 ($ millions)
Figure 75. GCC Countries Tumor Multigene Detection Kit Revenue Growth 2021-2026 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of Tumor Multigene Detection Kit in 2026
Figure 77. Manufacturing Process Analysis of Tumor Multigene Detection Kit
Figure 78. Industry Chain Structure of Tumor Multigene Detection Kit
Figure 79. Channels of Distribution
Figure 80. Global Tumor Multigene Detection Kit Sales Market Forecast by Region (2027-2032)
Figure 81. Global Tumor Multigene Detection Kit Revenue Market Share Forecast by Region (2027-2032)
Figure 82. Global Tumor Multigene Detection Kit Sales Market Share Forecast by Type (2027-2032)
Figure 83. Global Tumor Multigene Detection Kit Revenue Market Share Forecast by Type (2027-2032)
Figure 84. Global Tumor Multigene Detection Kit Sales Market Share Forecast by Application (2027-2032)
Figure 85. Global Tumor Multigene Detection Kit Revenue Market Share Forecast by Application (2027-2032)
